Fig. 1From: Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional studyFlow chart showing inclusion and exclusion criteria, and missing valuesBack to article page